GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » FCF Margin %

BYSI (BeyondSpring) FCF Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BeyondSpring's Free Cash Flow for the six months ended in Jun. 2024 was $0.00 Mil. BeyondSpring's Revenue for the six months ended in Jun. 2024 was $1.00 Mil. Therefore, BeyondSpring's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, BeyondSpring's current FCF Yield % is -26.50%.

The historical rank and industry rank for BeyondSpring's FCF Margin % or its related term are showing as below:

BYSI' s FCF Margin % Range Over the Past 10 Years
Min: -24331.67   Med: -2896.78   Max: -883.48
Current: -883.48


During the past 10 years, the highest FCF Margin % of BeyondSpring was -883.48%. The lowest was -24331.67%. And the median was -2896.78%.

BYSI's FCF Margin % is ranked worse than
73.59% of 1045 companies
in the Biotechnology industry
Industry Median: -145.32 vs BYSI: -883.48


BeyondSpring FCF Margin % Historical Data

The historical data trend for BeyondSpring's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring FCF Margin % Chart

BeyondSpring Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -24,331.67 -3,707.33 -2,086.23 -946.54

BeyondSpring Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BeyondSpring's FCF Margin %

For the Biotechnology subindustry, BeyondSpring's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeyondSpring's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeyondSpring's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BeyondSpring's FCF Margin % falls into.



BeyondSpring FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BeyondSpring's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-16.574/1.751
=-946.54 %

BeyondSpring's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0/1
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BeyondSpring FCF Margin % Related Terms

Thank you for viewing the detailed overview of BeyondSpring's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BeyondSpring Business Description

Traded in Other Exchanges
N/A
Address
100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, New Jersey, NJ, USA, 07932
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.